Corina Schneidawind

4PUBLICATIONS
4CO-AUTHORS
Molecular targetsHaematologyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 29, 2023
The RORÉ£/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.

Estelle Erkner, Thomas Hentrich, Rebekka Schairer

|Jun 11, 2020
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations.

Kathy-Ann Secker, Lukas Bruns, Hildegard Keppeler

|May 28, 2020
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis.

Kathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler

|Mar 28, 2019
G-CSF administration prior to donor lymphocyte apheresis promotes anti-leukaemic effects in allogeneic HCT patients.

Corina Schneidawind, Simona Jahnke, Irmtraud Schober-Melms

Pageof 1

Frequent Collaborators

2 joint publications

Thomas Hentrich

2 joint publications

Julia M Schulze-Hentrich

1 joint publications

Bianca Bloechl

1 joint publications

Claudia Lengerke